HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lycium barbarum polysaccharide

extracted from Lycium barbarum that is a kind of traditional Chinese herb, is found to have anticancer activity

Also Known As:

LBP herb

Networked: 73 relevant articles (11 outcomes, 15 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        lycium barbarum polysaccharide: 73
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - lycium barbarum polysaccharide: 73

Experts

1.	Zhao, Rui: 4 articles (06/2015 - 12/2005)
2.	Fan, Yan-Na: 3 articles (09/2021 - 07/2021)
3.	Gao, Lu-Lu: 3 articles (09/2021 - 07/2021)
4.	Gao, Qing-Han: 3 articles (09/2021 - 07/2021)
5.	Li, Yu-Xiang: 3 articles (09/2021 - 10/2017)
6.	Ma, Jia-Min: 3 articles (09/2021 - 07/2021)
7.	Tao, Xiu-Juan: 3 articles (09/2021 - 07/2021)
8.	Yang, Jian-Jun: 3 articles (09/2021 - 07/2021)
9.	Yu, Jian-Qiang: 3 articles (09/2021 - 10/2017)
10.	Zhang, Meng-Wei: 3 articles (09/2021 - 07/2021)

Related Diseases

1.	Non-alcoholic Fatty Liver Disease 11/08/2016 - "In this study, we aimed to investigate the protective effects and underlying mechanism of Lycium barbarum polysaccharide (LBP) on high-fat-induced nonalcoholic fatty liver disease (NAFLD). " 08/08/2022 - "Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK/PPARα/PGC-1α Pathway." 09/30/2021 - "Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial." 08/26/2021 - "Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial." 07/31/2021 - "Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation."
2.	Type 2 Diabetes Mellitus (MODY) 01/01/2023 - "Several studies showed the efficacy of Lycium barbarum polysaccharide (LBP) in diabetic animals and patients with type 2 diabetes mellitus (T2DM). " 01/01/2022 - "This study aims to explore the molecular mechanisms of Lycium barbarum polysaccharide (LBP) in alleviating type 2 diabetes through intestinal flora modulation. " 12/01/2005 - "Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats." 01/01/2015 - "Practical Application of Antidiabetic Efficacy of Lycium barbarum Polysaccharide in Patients with Type 2 Diabetes." 01/01/2022 - "Hypoglycemic Effects of Lycium barbarum Polysaccharide in Type 2 Diabetes Mellitus Mice via Modulating Gut Microbiota."
3.	Inflammation (Inflammations) 03/01/2021 - "Lycium barbarum polysaccharide (LBP), the main bioactive component of Chinese wolfberry, suppresses glycolysis and inflammation. " 03/01/2021 - "Lycium barbarum Polysaccharide Antagonizes LPS-Induced Inflammation by Altering the Glycolysis and Differentiation of Macrophages by Triggering the Degradation of PKM2." 04/01/2018 - "Lycium barbarum polysaccharide protects against LPS-induced ARDS by inhibiting apoptosis, oxidative stress, and inflammation in pulmonary endothelial cells." 07/01/2020 - "Lycium barbarum Polysaccharide Extracted from Lycium barbarum Leaves Ameliorates Asthma in Mice by Reducing Inflammation and Modulating Gut Microbiota." 07/01/2020 - "This study was designed to explore the impact of Lycium barbarum polysaccharide (LBP) on inflammation and gut microbiota in mice with allergic asthma. "
4.	Reperfusion Injury 07/01/2015 - "To observe the protective effects of Lycium barbarum polysaccharide(LBP) on focal cerebral ischemic reperfusion injury in mice, and to explore its mechanism. " 11/01/2021 - "Lycium barbarum polysaccharide protects rats and cardiomyocytes against ischemia/reperfusion injury via Nrf2 activation through autophagy inhibition." 07/01/2015 - "[Lycium barbarum Polysaccharide Pretreatment Attenuates Cerebral Ischemic Reperfusion Injury by Inhibiting Apoptosis in Mice]." 01/31/2023 - "The aim of this study was to examine the effects and underlying molecular mechanisms of Lycium barbarum polysaccharide (LBP) on myocardial ischemia-reperfusion injury in cardiomyocytes. " 10/01/2022 - "Potential cerebrovascular protective functions of lycium barbarum polysaccharide in alleviating hyperglycemia-aggravated cerebral ischemia/reperfusion injury in hyperglycemic rats."
5.	Insulin Resistance 01/01/2014 - "Dietary Lycium barbarum polysaccharide induces Nrf2/ARE pathway and ameliorates insulin resistance induced by high-fat via activation of PI3K/AKT signaling." 04/01/2014 - "Lycium barbarum polysaccharide (LBP) has been shown to ameliorate insulin resistance, but the identification of compounds from LBP and the mechanisms have not been clarified. " 12/01/2005 - "Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats." 01/01/2014 - "Lycium barbarum polysaccharide (LBP), an antioxidant from wolfberry, displays the antioxidative and anti-inflammatory effects on experimental models of insulin resistance in vivo. " 12/01/2005 - "In this study, the effect of Lycium barbarum polysaccharide (LBP) on the improvement of insulin resistance and lipid profile was studied in rats, a model for non-insulin dependent diabetes mellitus (NIDDM). "

Related Drugs and Biologics

1.	Hypoglycemic Agents (Hypoglycemics)
2.	Ophthalmic Solutions (Eye Drops)
3.	Doxorubicin (Adriamycin)
4.	Streptozocin (Streptozotocin)
5.	Tablets
6.	Solutions
7.	Polysaccharides (Glycans)
8.	Lipids
9.	Antioxidants
10.	Therapeutic Uses

Related Therapies and Procedures

1.	Topical Administration
2.	Photothermal Therapy
3.	Surgical Instruments (Clip)
4.	Chinese Traditional Medicine (Traditional Chinese Medicine)
5.	Ligation